GGrantIndex
Sort

30,917 grants matching tumor microenvironment

An In Situ Patient-specific Chemo-Immunotherapy for Skin Cancers

$388,443
Louis D Falo · University Of Pittsburgh At Pittsburgh · P50 · FY2013 · CA

Biochemistry of MT1-MMP activation in malignancy

$388,440
Alex Y Strongin · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA

Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence

$388,438
Sofia Diana Merajver · University Of Michigan At Ann Arbor · R33 · FY2022 · CA

IPMK function in chromatin

$388,435
Raymond Daniel Blind · Vanderbilt University Medical Center · R01 · FY2021 · GM

Role of type 2 immune response in pancreatic cancer tumorigenesis

$388,432
Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA

Regulation of T cell activation and exhaustion by Tim-3

$388,425
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · AI

Regulation of T cell activation and exhaustion by Tim-3

$388,425
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · AI

Regulation of T cell activation and exhaustion by Tim-3

$388,425
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AI

Regulation of T cell activation and exhaustion by Tim-3

$388,425
Lawrence P Kane · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AI

MetaboCore: Needle biopsy assay of drug sensitivity for solid tumors.

$388,418
Raymond Yeung · University Of Washington · U01 · FY2025 · CA

(PQ7) Quantitative in vivo optical imaging of tumor heterogeneity

$388,402
Melissa Caroline Skala · Morgridge Institute For Research, Inc. · R01 · FY2017 · CA

Microglial Kynurenine Pathway and Selective Neuronal Vulnerability

$388,397
Paul J Muchowski · J. David Gladstone Institutes · P01 · FY2009 · AG

The Role of Cancer-Associated Fibroblasts in Thyroid Carcinoma

$388,315
Vivian Lee Weiss · Vanderbilt University Medical Center · R01 · FY2023 · CA

Core C: Biospecimen, Pathology, and Genomics Core

$388,312
David L Rimm · Yale University · P50 · FY2024 · CA

Cancer-Associated Fibroblasts Alter the Composition of B cells in Solid Malignancies

$388,303
Sandra Orsulic · Cedars-Sinai Medical Center · R01 · FY2019 · CA

Reprogramming myeloid cells to inhibit cancer development

$388,283
Chengcheng Zhang · Ut Southwestern Medical Center · R01 · FY2022 · CA

Managing Microenvironment-mediated Heterogeneity and Resistance

$388,272
Laura Madeline Heiser · Oregon Health & Science University · U54 · FY2020 · CA

Trafficking of eRNAs in K-Ras Mutant Colon Cancer

$388,264
Robert J Coffey · Vanderbilt University · U19 · FY2014 · CA

An ex vivo system to model the inflammatory microenvironment of human disc herniation

$388,230
Xudong Joshua Li · University Of Virginia · R21 · FY2021 · AR

Regulation of Organized Intestinal Lymphoid Tissues by TRANCE/RANKL

$388,230
Ifor R Williams · Emory University · R01 · FY2012 · DK

In vivo murine models of metastasis for therapeutic testing

$388,202
Norman Edward Sharpless · Univ Of North Carolina Chapel Hill · R01 · FY2014 · CA

Amyloid-bodies and the Evolution of Malignancies

$388,191
Stephen Lee · University Of Miami School Of Medicine · R01 · FY2023 · CA

Impact of extracellular glutathione catabolism on triple-negative breast cancer

$388,174
Isaac Spencer Harris · University Of Rochester · R01 · FY2022 · CA

Targeted delivery of immunomodulatory biologics for induction of immune privilege to allogeneic pancreatic islet grafts

$388,154
Haval Shirwan · University Of Louisville · U01 · FY2019 · AI

Project 7 - Metformin

$388,082
Ernst Lengyel · Mayo Clinic Rochester · P50 · FY2019 · CA